Seng, Kok-Yong
1032  Ergebnisse:
Personensuche X
?
1

Activity of faropenem with and without rifampicin against M..:

Gurumurthy, Meera ; Verma, Rupangi ; Naftalin, Claire M....
Journal of Antimicrobial Chemotherapy.  72 (2017)  7 - p. 2012-2019 , 2017
 
?
2

Tracking body core temperature in military thermal environm..:

, In: 2016 IEEE 13th International Conference on Wearable and Implantable Body Sensor Networks (BSN),
Seng, Kok-Yong ; Chen, Ying ; Chai, Kian Ming A.... - p. 296-299 , 2016
 
?
4

Population pharmacokinetics of rifampicin and 25-deacetyl-r..:

Seng, Kok-Yong ; Hee, Kim-Hor ; Soon, Gaik-Hong...
Journal of Antimicrobial Chemotherapy.  70 (2015)  12 - p. 3298-3306 , 2015
 
?
5

CYP3A5*3 and bilirubin predict midazolam population pharmac..:

Seng, Kok-Yong ; Hee, Kim-Hor ; Soon, Gaik Hong...
The Journal of Clinical Pharmacology.  54 (2013)  2 - p. 215-224 , 2013
 
?
6

Retrospective population pharmacokinetic/pharmacodynamic an..:

Seng, Kok-Yong ; Loke, Weng-Keong ; Moochhala, Shabbir..
Journal of Pharmacy and Pharmacology.  61 (2010)  9 - p. 1187-1196 , 2010
 
?
7

Comparison of Statistical Data Models for Identifying Diffe..:

Seng, Kok-Yong ; Glenny, Robb W. ; Madtes, David K....
Gene Regulation and Systems Biology.  2 (2008)  - p. GRSB.S381 , 2008
 
?
9

Objective quantification of acetylcholine receptor aggregat..:

Seng, Kok-Yong ; Figueroa-Masot, Xavier ; Folch, Albert.
Computer Methods and Programs in Biomedicine.  85 (2007)  3 - p. 220-228 , 2007
 
?
10

Simulating pharmacokinetic and pharmacodynamic fuzzy-parame..:

Seng, Kok-Yong ; Nestorov, Ivan ; Vicini, Paolo
Journal of Pharmacokinetics and Pharmacodynamics.  34 (2007)  5 - p. 595-621 , 2007
 
?
 
1-15